胰岛素样生长因子结合蛋白样1抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 胰岛素样生长因子结合蛋白样1抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

IGFBPL1 is a secreted IGF (Insulin-like growth factor) binding protein that is known to contain an Ig-like C2-type (immunoglobulin-like) domain, an IGFBP N-terminal domain and a Kazal-like domain. IGF-binding proteins characteristically act to extend the half-life of 胰岛素样生长因子结合蛋白样1抗体 IGFs and may influence the growth promoting effects of the IGFs. The interaction of IGFBPs with IGFs can affect cell surface receptors, specifically, IGFBPs may enhance or decrease a cells insulin sensitivity. IGFBPL1 has been found to be down-regulated in multiple tumors and thus may be a likely tumor suppressor candidate. Highly expressed in both brain and testis, IGFBPL1 is found at lower levels in the prostate, bladder and lung.

胰岛素样生长因子结合蛋白样1抗体 Also known as:

bA113O24.1; IGFBP-related protein 10; IGFBP-RP4; IGFBPRP4; insulin-like growth factor binding protein related protein 4; insulin-like growth factor-binding protein-like 1; IBPL1_HUMAN; insulin-like growth factor-binding-related protein 4.

Specificity:

●

Rabbit Polyclonal IgG,胰岛素样生长因子结合蛋白样1抗体  affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human IGFBPL1.

●

胰岛素样生长因子结合蛋白样1抗体 

kl054Hu01S100钙结合蛋白P(S100P)多克隆抗体Polyclonal Antibody to S100 Calcium Binding Protein P (S100P)

kl056Hu01基质金属蛋白酶14(MMP14)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)

kl056Mu01基质金属蛋白酶14(MMP14)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)

kl057Hu01核因子κB受体激活因子(RANκ)多克隆抗体Polyclonal Antibody to Receptor Activator Of Nuclear Factor Kappa B (RANk)

kl057Ra01核因子κB受体激活因子(RANκ)多克隆抗体Polyclonal Antibody to Receptor Activator Of Nuclear Factor Kappa B (RANk)

kl058Hu01白介素20(IL20)多克隆抗体Polyclonal Antibody to Interleukin 20 (IL20)

kl060Hu01血小板衍生生长因子受体α(PDGFRα)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Receptor Alpha (PDGFRa)

kl060Ra01血小板衍生生长因子受体α(PDGFRα)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Receptor Alpha (PDGFRa)

kl061Hu01血小板衍生生长因子受体β(PDGFRβ)多克隆抗体Polyclonal Antibody to Platelet Derived Growth Factor Receptor Beta (PDGFRb)

kl064Hu01白介素24(IL24)多克隆抗体Polyclonal Antibody to Interleukin 24 (IL24)

kl064Mu01白介素24(IL24)多克隆抗体Polyclonal Antibody to Interleukin 24 (IL24)

kl065Hu01透明质酸介导运动因子受体(HMMR)多克隆抗体Polyclonal Antibody to Hyaluronan Mediated Motility Receptor (HMMR)

kl066Hu01双氧化酶2(DUOX2)多克隆抗体Polyclonal Antibody to Dual Oxidase 2 (DUOX2)

kl066Ra01双氧化酶2(DUOX2)多克隆抗体Polyclonal Antibody to Dual Oxidase 2 (DUOX2)

kl067Hu01去唾液酸糖蛋白受体2(ASGR2)多克隆抗体Polyclonal Antibody to Asialoglycoprotein Receptor 2 (ASGR2)

kl068Hu01VEGF共调节趋化因子1(VCC1)多克隆抗体Polyclonal Antibody to VEGF Co Regulated Chemokine 1 (VCC1)

kl070Hu01趋化因子C-基元配体2(XCL2)多克隆抗体Polyclonal Antibody to Chemokine C-Motif Ligand 2 (XCL2)

kl071Bo01干扰素诱导T-细胞α亚族趋化剂(ITαC)多克隆抗体Polyclonal Antibody to Interferon Inducible T-Cell Alpha Chemoattractant (ITaC)

kl071Ra01干扰素诱导T-细胞α亚族趋化剂(ITαC)多克隆抗体Polyclonal Antibody to Interferon Inducible T-Cell Alpha Chemoattractant (ITaC)

kl076Hu01层粘连蛋白α3(LAMα3)多克隆抗体Polyclonal Antibody to Laminin Alpha 3 (LAMa3)

kl077Hu01层粘连蛋白α4(LAMα4)多克隆抗体Polyclonal Antibody to Laminin Alpha 4 (LAMa4)

kl078Hu01层粘连蛋白α5(LAMα5)多克隆抗体Polyclonal Antibody to Laminin Alpha 5 (LAMa5)

kl080Hu01层粘连蛋白β2(LAMβ2)多克隆抗体Polyclonal Antibody to Laminin Beta 2 (LAMb2)

kl081Hu01层粘连蛋白β3(LAMβ3)多克隆抗体Polyclonal Antibody to Laminin Beta 3 (LAMb3)

kl083Hu01层粘连蛋白γ2(LAMγ2)多克隆抗体Polyclonal Antibody to Laminin Gamma 2 (LAMC2)

kl086Hu01Ⅰ类主要组织相容性复合体C(MHCC)多克隆抗体Polyclonal Antibody to Major Histocomklibility Complex Class I C (MHCC)

kl097Hu01整合素α11(ITGα11)多克隆抗体Polyclonal Antibody to Integrin Alpha 11 (ITGa11)

Predicted Molecular Weight: 26kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.